The purpose of this study is to understand how placing Amnioeffect on patients having transcutaneous thyroid or parathyroid surgery affects surgery scar appearance, pain, and the ability to swallow and compare it to patients who do not have anything placed during surgery. The Food and Drug Administration regulates the use of Amnioeffect for homologous use. Both Amnioeffect application and no Amnioeffect application are considered standard of care; however, for the purpose of this study, the use of Amnioeffect during surgery will be considered the intervention, and no Amnioeffect application will be the standard of care.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Improvement of scar appearance
Timeframe: Pre-procedure, 1 month post procedure, 3 months post procedure
Determine swallowing effectiveness
Timeframe: Pre-procedure, 1 month post procedure, 3 months post procedure
Improvement in Pain Score
Timeframe: Pre-procedure, 1 month post procedure, 3 months post procedure